Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Isabelle Melki

Showing results (71-80 of 102) with videos related to

Pageof 11
Sort By:
Pediatric Blood & Cancer|January 28, 2025
Systemic Inflammatory Diseases in Children With Sickle Cell Disease: A French Multicenter Observational Study on Diagnostic and Therapeutic IssuesCaroline Vinit, Corinne Guitton, Mariane De Montalembert, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2021
Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient childRomain Lévy, Peng Zhang, Paul Bastard, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 13, 2017
Musculoskeletal Disease in MDA5-Related Type I Interferonopathy: A Mendelian Mimic of Jaccoud's ArthropathyLuciana Martins de Carvalho, Gonza Ngoumou, Ji Woo Park, et al.
European Journal of Human Genetics : EJHG|April 24, 2018
A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experienceMélanie Rama, Claire Duflos, Isabelle Melki, et al.
Rheumatology (Oxford, England)|April 25, 2025
Indications, efficacy, safety of rituximab in childhood-onset systemic lupus erythematosus: a retrospective study of the JIR cohortJade Cognard, Christine Pietrement, Audrey Laurent, et al.
Lupus|February 5, 2024
Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability scoreMathilde Labouret, Vincent Trebossen, Alexandra Ntorkou, et al.
Annals of the Rheumatic Diseases|June 13, 2020
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohortMarie Pouletty, Charlotte Borocco, Naim Ouldali, et al.
Annals of Intensive Care|March 24, 2025
Anti-RNApol3-Associated myocarditis: an emerging disease linking autoimmunity and infectionPaul Quentric, Jean-Luc Charuel, Quentin Moyon, et al.
Annals of the Rheumatic Diseases|March 26, 2022
Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseasesLianne Kearsley-Fleet, Min-Lee Chang, Saskia Lawson-Tovey, et al.
British Journal of Clinical Pharmacology|May 24, 2025
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activityNaïm Bouazza, Michaela Semeraro, Gabrielle Lui, et al.
Pageof 11

Showing results (71-80 of 102) with videos related to

Sort By:
Pageof 11
Pediatric Blood & Cancer|January 28, 2025
Systemic Inflammatory Diseases in Children With Sickle Cell Disease: A French Multicenter Observational Study on Diagnostic and Therapeutic IssuesCaroline Vinit, Corinne Guitton, Mariane De Montalembert, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 27, 2021
Monoclonal antibody-mediated neutralization of SARS-CoV-2 in an IRF9-deficient childRomain Lévy, Peng Zhang, Paul Bastard, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|June 13, 2017
Musculoskeletal Disease in MDA5-Related Type I Interferonopathy: A Mendelian Mimic of Jaccoud's ArthropathyLuciana Martins de Carvalho, Gonza Ngoumou, Ji Woo Park, et al.
European Journal of Human Genetics : EJHG|April 24, 2018
A decision tree for the genetic diagnosis of deficiency of adenosine deaminase 2 (DADA2): a French reference centres experienceMélanie Rama, Claire Duflos, Isabelle Melki, et al.
Rheumatology (Oxford, England)|April 25, 2025
Indications, efficacy, safety of rituximab in childhood-onset systemic lupus erythematosus: a retrospective study of the JIR cohortJade Cognard, Christine Pietrement, Audrey Laurent, et al.
Lupus|February 5, 2024
Juvenile neuropsychiatric systemic lupus erythematosus: A specific clinical phenotype and proposal of a probability scoreMathilde Labouret, Vincent Trebossen, Alexandra Ntorkou, et al.
Annals of the Rheumatic Diseases|June 13, 2020
Paediatric multisystem inflammatory syndrome temporally associated with SARS-CoV-2 mimicking Kawasaki disease (Kawa-COVID-19): a multicentre cohortMarie Pouletty, Charlotte Borocco, Naim Ouldali, et al.
Annals of Intensive Care|March 24, 2025
Anti-RNApol3-Associated myocarditis: an emerging disease linking autoimmunity and infectionPaul Quentric, Jean-Luc Charuel, Quentin Moyon, et al.
Annals of the Rheumatic Diseases|March 26, 2022
Outcomes of SARS-CoV-2 infection among children and young people with pre-existing rheumatic and musculoskeletal diseasesLianne Kearsley-Fleet, Min-Lee Chang, Saskia Lawson-Tovey, et al.
British Journal of Clinical Pharmacology|May 24, 2025
Population pharmacokinetic modelling of prednisolone in systemic lupus erythematosus patients: Analysis of exposure and disease activityNaïm Bouazza, Michaela Semeraro, Gabrielle Lui, et al.
Pageof 11